Results 31 to 40 of about 49,037 (222)

Implant Removal in the Management of Prosthetic Joint Infection by Staphylococcus aureus: Outcome and Predictors of Failure in a Large Retrospective Multicenter Study

Antibiotics, 2021
Objectives: To compare the characteristics and outcomes of cases with acute prosthetic joint infection (PJI; early post-surgical or hematogenous) by Staphylococcus aureus managed with implant removal (IRm) or debridement and retention (DAIR).
Joan Gómez-Junyent, Jaime Lora-Tamayo, Josu Baraia-Etxaburu, Mar Sánchez-Somolinos, Jose Antonio Iribarren, Dolors Rodriguez-Pardo, Julia Praena-Segovia, Luisa Sorlí, Alberto Bahamonde, Melchor Riera, Alicia Rico, Mª Dolores del Toro, Laura Morata, Javier Cobo, Luis Falgueras, Natividad Benito, Elena Muñez, Alfredo Jover-Sáenz, Carles Pigrau, Javier Ariza, Oscar Murillo   +20 more
doaj   +1 more source

Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis

Antibiotics, 2021
Introduction: E. faecium and E. faecalis are responsible for 13.9% of hospital-acquired infections with frequent resistance to vancomycin (82.6% of E. faecium, 9.5% of E. faecalis).
Katie E. Barber, Zade Shammout, Jordan R. Smith, Razieh Kebriaei, Taylor Morrisette, Michael J. Rybak   +5 more
doaj   +1 more source

Factors Associated with Variability in Rifampin Plasma Pharmacokinetics and the Relationship between Rifampin Concentrations and Induction of Efavirenz Clearance [PDF]

, 2014
Study Objectives To identify factors associated with variability in rifampin plasma pharmacokinetics and explore the relationship between rifampin pharmacokinetics and change in efavirenz plasma pharmacokinetics with rifampin coadministration. Methods In
Behrang D. Mahjoub, Cao, Lei, Court, Michael H, Mahjoub, Behrang D, Charles A. Peloquin, Yang, Hongmei, Lei Cao, Poethke, Pamela, Kwara, Awewura, Michael H. Court, Peloquin, Charles A, Pamela Poethke, Karen T. Tashima, Tashima, Karen T, Jaclynn Kurpewski, Awewura Kwara, Hongmei Yang, Kurpewski, Jaclynn   +17 more
core   +1 more source

High-dose rifampin improves bactericidal activity without increased intracerebral inflammation in animal models of tuberculous meningitis

The Journal of Clinical Investigation, 2022
Tuberculous meningitis (TB meningitis) is the most severe form of tuberculosis (TB), requiring 12 months of multidrug treatment for cure, and is associated with high morbidity and mortality.
Camilo A. Ruiz-Bedoya, Filipa Mota, Elizabeth W. Tucker, Farina J. Mahmud, Maria I. Reyes-Mantilla, Clara Erice, Melissa Bahr, Kelly Flavahan, Patricia de Jesus, John Kim, Catherine A. Foss, Charles A. Peloquin, Dima A. Hammoud, Alvaro A. Ordonez, Carlos A. Pardo, Sanjay K. Jain   +15 more
doaj   +1 more source

Deciphering the Molecular Basis for Attenuation of Flavobacterium columnare Strain Fc1723 Used as Modified Live Vaccine against Columnaris Disease

Vaccines, 2021
Vaccines are widely employed in aquaculture to prevent bacterial infections, but their use by the U.S. catfish industry is very limited. One of the main diseases affecting catfish aquaculture is columnaris disease, caused by the bacterial pathogen ...
Wenlong Cai, Covadonga R. Arias
doaj   +1 more source

TB = Tuberculosis, RS-TB = rifampin sensitive M. tuberculosis, RR-TB = rifampin resistant M. tuberculosis. [PDF]

, 2013
6 of 12 patients who had rifampin resistant M. tuberculosis at initial tuberculosis diagnosis, re-cultured rifampin resistant M. tuberculosis at clinical deterioration. i.e. 29 new cases of rifampin resistant M.
Graeme Meintjes (221054), Chelsea Morroni (374326), Dominique J. Pepper (221049), Robert J. Wilkinson (130050), Kevin Rebe (374325)   +4 more
core   +1 more source

Doses of rifampin by weight band. [PDF]

, 2023
Doses of rifampin by weight band.
Victoria Cook (14559272), Dina Fisher (574945), Richard Long (105563), Greg J. Fox (7022687), Rovina Ruslami (6324572), Thu Anh Nguyen (10734756), Leila Barss (6598055), James Johnston (2008615), Dick Menzies (66118), Federica Fregonese (442412), Andrea Benedetti (139371), Lika Apriani (12175822), Viet Nhung Nguyen (3213090)   +12 more
core   +1 more source

Sigma Factor F does not Prevent Rifampin Inhibition of RNA Polymerase or Cause Rifampin Tolerance in Mycobacterium tuberculosis [PDF]

, 2010
The tolerance of Mycobacterium tuberculosis to anti-tuberculosis drugs is a major reason for the lengthy therapy needed to treat a tuberculosis infection.
Cole, Stewart T, Jeffrey M. Chen, Stewart T. Cole, Hartkoorn, Ruben C, Sala, Claudia, Magnet, Sophie J, Ruben C. Hartkoorn, Florence Pojer, Pojer, Florence, Claudia Sala, Sophie J. Magnet, Chen, Jeffrey M   +11 more
core   +1 more source

A Case of Acquired Rifampin Resistance in Mycobacterium bovis Bacillus Calmette-Guérin-Induced Cystitis: Necessity for Treatment Guidelines

Canadian Journal of Infectious Diseases and Medical Microbiology, 2006
A case of presumed bacillus Calmette-Guérin (BCG) cystitis in an elderly female patient following direct intravesical BCG instillation treatment for papillary transitional cell carcinoma is reported.
Joyce N Wolfe, Kym S Blackwood-Antonation, Meenu K Sharma, Victoria J Cook   +3 more
doaj   +1 more source

Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations [PDF]

, 2001
Rifampin is the most potent drug used in the treatment of disease due to Mycobacterium kansasii. A 69-bp fragment of rpoB, the gene that encodes the beta subunit of the bacterial RNA polymerase, was sequenced and found to be identical in five rifampin ...
Klein, J L, Brown, T J, French, G L
core   +1 more source